The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure
Fissure in Ano, Diarrhea
About this trial
This is an interventional treatment trial for Fissure in Ano focused on measuring Acute fissure, Diarrhea, Asacol
Eligibility Criteria
Inclusion Criteria:
For age between 18 and 65 years are the presence of acute anal fissure (with symptoms less than 6 weeks) following chronic diarrhea and subsequent fissure.
Exclusion Criteria:
- Recurrent fissure with skin appendage.
- Long history of constipation.
- Use of immunosuppressive drugs or corticosteroids.
- Inflammatory bowel disease such as Crohn's disease and ulcerative colitis.
- Pregnancy.
- Grade 3 and 4 hemorrhoids.
- Neurological disease.
- Obsessive-compulsive disorder.
- Previous history of anal surgery
- Skin diseases such as eczema and psoriasis.
- Sexually transmitted infections, tuberculosis.
- Mucosal prolapse.
- Anal fistula and pelvic radiotherapy.
Sites / Locations
- Leila Ghahramani
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Standard management of acute fissure(Diltiazem Jelly,supportive care,placebo suppository, sitz bath)
Intervention group (Asacol suppository, supportive care, placebo suppository, sitz bath)
Patients in the first group underwent for 14 consecutive days treatment with diltiazem gel 2 times a day, a basin of warm water 2 times a day and drink daily 8-12 a glass of water will be placed with a placebo suppository.
Patients in the second group or treatment group will be treated with diltiazem gel topically 3 times a day for 14 consecutive days, pelvis of warm water 2 times a day and drink daily 8-12 glasses of water plus Asacol anal suppository (mesalazine) are taken 1 piece every night.